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Irrespective of the recommendations to use the measurement of serum
TSH as cornerstone of thyroid function testing. The laboratory
diagnosis and monitoring of thyroid disease are based on the thyroid
panel including TSH,FT4,TT4,TT3,FT3,ANTI –TPO and ANTI-TG are
essential to manage thyroid diseases. Autoimmune thyroid diseases
including Groves disease, Hashimoto thyroiditis. Hashimoto's
thyroiditis is an autoimmune disorder, and these types of disorders are
caused by immune system malfunction. In other words, instead of
protecting the body's healthy tissues, malfunctioning immune cells
actually attack them.
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Serum levels of anti-TPO and anti-TG in the examined and control group 
Hormone Examined group Control group 
Anti-TPO 238.5 ± 0.95 3.7 ± 0.46 
P<0.001
Anti-TG 333.3 ± 0.55 167.4 ± 57.5 
To compare serum anti-TPO and anti-TG levels between patients with
Groves disease, Hashimoto thyroiditis, and healthy controls. This
test is commonly used to confirm or exclude Hashimoto's thyroiditis.
as the reason for hypothyroidism.
Anti-thyroid antibodies tests, such as the microsomal antibody
test (also known as thyroid peroxidase antibody test) and the
anti-thyroglobulin antibody test, are commonly used to detect
the presence of Hashimoto's thyroiditis.
Serum concentration anti –TPO and anti-TG , other thyroid
hormones were determined by analyzer chemiluminescence
immunoassay of CLIA methods Immulite 2000.
Measurements of antithyroid peroxidase (TPO) have higher 
sensitivity and equal specificity to antithyroglobulin (anti-Tg) 
measurements in the diagnosis of autoimmune thyroid disease. 
Anti-Tg levels should, therefore, only be measured if anti-TPO 
measurements are negative, but clinical suspicion of 
autoimmune thyroid disease is high. Detection of significant 
titers of anti-Tg or anti-TPO autoantibodies is supportive 
evidence for a diagnosis of Graves disease in patients with 
thyrotoxicosis .
Serum concentrations of anti-TPO and anti-TG respectively of 
organ specific autoantibodies are very precious parameter -
marker for  make true and fast  thyroid diagnosis.
In this clinical study were assessed for prospective morning 
serum concentrations of anti-TPO in 50 subjects with  Groves 
disease, Hashimoto thyroiditis,  and 40 healthy subjects 
Material
Patients with Groves disease, Hashimoto thyroiditis
showed significantly higher concentrations of anti-TPO
and anti-TG compared with healthy individuals.(P<0.001).
Values ​​of anti-TPO in the control group (3.7± 0.46) was
the value of anti-TPO in patients diagnosed with sc
Groves disease, Hashimoto thyroiditis (238,5 ± 0.95),
and values of anti-TG in the control group (333,3± 0.55).
There is no statistical difference between values of anti-
TPO and thyroid hormones.
In individuals with autoimmune hypothyroidism, 30% to
50% will have detectable anti-Tg , while 50% to 90% will
have detectable anti-TPO. In Graves disease, both types
of autoantibodies are observed at approximately half
these rates. Since anti-Tg and anti-TPO autoantibodies
are observed most frequently in autoimmune thyroiditis
(Hashimoto disease), they were originally considered to
be of possible pathogenic significance in this disorder.
However, the consensus opinion today is that they are
merely disease markers. It is felt that the presence of
competent immune cells at the site of thyroid tissue
destruction in autoimmune thyroiditis simply
predisposes the patient to form autoantibodies to hidden
thyroid antigens.
.
Figure 1. Values Anti-TPO and Anti-TG  in the 
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Thyroid autoimmune disease is the major factor underlying
hypothyroidism and hyperthyroidism and tends to occur in a
genetically predisposed population. The major thyroid autoimmune
diseases are: Hashimotoʼs diseases and Gravesʼ diseases.
Introduction Results and Discusion
Method of investigation
Corresponding author:
Danijela Janicevic Ivanovska 
E-mail: djanicevic@yahoo.com
Aim of the study
1. Gharib H, Tuttle RM, Baskin HJ, et al: Consensus Statement #1, Subclinical thyroid 
dysfunction: a joint statement on management from the American Association of 
Clinical Endocrinologists, The American Thyroid Association, and The Endocrine 
Society. Thyroid 2005;15:24-28.
2. Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of 
thyrotoxicosis: management guidelines of the American Thyroid Association and 
American Association of Clinical Endocrinologists. Endocr Pract. 2011 May-Jun. 17 
(3):456-520. [Medline]. [Full Text]. 
3. [Guideline] Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid 
Association Guidelines for Diagnosis and Management of Hyperthyroidism and 
Other Causes of Thyrotoxicosis. Thyroid. 2016 Oct. 26 (10):1343-
421. [Medline]. [Full Text]. 
4. Rabon S, Burton AM, White PC. Graves' Disease in Children: Long Term Outcomes 
of Medical Therapy. Clin Endocrinol (Oxf). 2016 May 12. [Medline].
5. Chong HW, See KC, Phua J. Thyroid storm with multiorgan failure. Thyroid. Mar 
2010. 20(3):333-6. [Medline].
6. Basaria S, Cooper DS. Amiodarone and the thyroid. Am J Med. 2005 
Jul.118(7):70614. 
7. Sapin P, d’Herbomez M, Gasser F, et al: Increased sensitivity of a new assay for 
anti-thyroglobulin antibody detection in patients with autoimmune thyroid disease. 
Clin Biochem 2003 Nov;36(8):611-616
Serum levels of anti-TPO and anti-TG in the examined and control group 
Hormone Examined group Control group 
Anti-TPO 238.5 ± 0.95 3.7 ± 0.46 
P<0.001
Anti-TG 333.3 ± 0.55 167.4 ± 57.5 
To compare serum anti-TPO and anti-TG levels between patients with
Groves disease, Hashimoto thyroiditis, and healthy controls. This
test is commonly used to confirm or exclude Hashimoto's thyroiditis.
as the reason for hypothyroidism.
Quantitative measurement of antithyroid peroxidase (TPO)
antibodies and autoantibodies to thyroglobulin (TG) in serum,
EDTA, and heparinized plasma, as an aid in the clinical
diagnosis of thyroid diseases. Serum concentration of Anti –
TPO Ab and anti – TG Ab were determined by are a solid-phase,
enzyme – labeled, chemiluminescent sequential immunometric
assays using analyzer Immulite 2000.
The consensus opinion today is that they are merely disease 
markers. It is felt that the presence of competent immune cells at 
the site of thyroid tissue destruction in autoimmune thyroiditis 
simply predisposes the patient to form autoantibodies to hidden 
thyroid antigens.
.  
In this clinical study were assessed for prospective morning 
serum concentrations of anti-TPO in 50 subjects with  Groves 
disease, Hashimoto thyroiditis,  and 40 healthy subjects 
Material
30% to 50% of individuals with autoimmune 
hypothyroidism, will have detectable  anti-Tg
autoantibodies, while 50% to 90%  will have detectable 
anti – TPO autoantibodies. In Gravesʼ disease, both 
types of autoantibodies are observed at 
approximately half of these rates. 10 percent of 
healthy individuals have TG autoantibodies at low 
levels, higher concentracions are found in 30 and 85 
percent of patients with  Gravesʼ diseases and 
Hashimotoʼs thyroiditis, respectively.
Patients with Graves disease and Hashimoto 
thyroiditis showed significantly higher concentrations 
of anti-TPO and anti-TG compared with healthy 
individuals. (P <0.001). Following results were 
obtained: values ​​of anti-TPO in patients diagnosed 
with sc Groves disease compared to the control group 
were 3.7± 0.46, and in patients with Hashimoto 
thyroiditis 238,5 ± 0.95. Values of anti-TG in patients 
diagnosed with sc Groves disease compared to the 
control group were 333,3 ± 0.55, Hashimoto 
thyroiditis 500,5 ± 0.95.  
.
Figure 1. Values Anti-TPO and Anti-TG  in the 
examined group and control group
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